GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BetterLife Pharma Inc (STU:NPAU) » Definitions » Liabilities-to-Assets

BetterLife Pharma (STU:NPAU) Liabilities-to-Assets : 24.71 (As of Jan. 2024)


View and export this data going back to 2018. Start your Free Trial

What is BetterLife Pharma Liabilities-to-Assets?

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. BetterLife Pharma's Total Liabilities for the quarter that ended in Jan. 2024 was €5.49 Mil. BetterLife Pharma's Total Assets for the quarter that ended in Jan. 2024 was €0.22 Mil. Therefore, BetterLife Pharma's Liabilities-to-Assets Ratio for the quarter that ended in Jan. 2024 was 24.71.


BetterLife Pharma Liabilities-to-Assets Historical Data

The historical data trend for BetterLife Pharma's Liabilities-to-Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BetterLife Pharma Liabilities-to-Assets Chart

BetterLife Pharma Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
Liabilities-to-Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.68 4.38 4.34 101.15 24.71

BetterLife Pharma Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Liabilities-to-Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 101.15 9.87 18.42 14.10 24.71

Competitive Comparison of BetterLife Pharma's Liabilities-to-Assets

For the Biotechnology subindustry, BetterLife Pharma's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BetterLife Pharma's Liabilities-to-Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BetterLife Pharma's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where BetterLife Pharma's Liabilities-to-Assets falls into.



BetterLife Pharma Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

BetterLife Pharma's Liabilities-to-Assets Ratio for the fiscal year that ended in Jan. 2024 is calculated as:

Liabilities-to-Assets (A: Jan. 2024 )=Total Liabilities/Total Assets
=5.486/0.222
=24.71

BetterLife Pharma's Liabilities-to-Assets Ratio for the quarter that ended in Jan. 2024 is calculated as

Liabilities-to-Assets (Q: Jan. 2024 )=Total Liabilities/Total Assets
=5.486/0.222
=24.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BetterLife Pharma  (STU:NPAU) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.


BetterLife Pharma Liabilities-to-Assets Related Terms

Thank you for viewing the detailed overview of BetterLife Pharma's Liabilities-to-Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


BetterLife Pharma (STU:NPAU) Business Description

Traded in Other Exchanges
Address
1275 West 6th Avenue, Suite 300, Vancouver, BC, CAN, V6H 1A6
BetterLife Pharma Inc a biotechnology company, engages in the development and commercialization of psychedelic products for the treatment of mental disorders in Canada, the United States, Australia, and European Union. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections, such as coronavirus disease and human papillomavirus, and/or to directly inhibit tumors to treat various types of cancer.

BetterLife Pharma (STU:NPAU) Headlines

No Headlines